KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Asset Utilization Ratio (2019 - 2025)

Vir Biotechnology's Asset Utilization Ratio history spans 7 years, with the latest figure at 0.07 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 41.26% year-over-year to 0.07; the TTM value through Dec 2025 reached 0.07, up 41.26%, while the annual FY2025 figure was 0.06, 27.63% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.07 at Vir Biotechnology, up from 0.02 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.96 in Q1 2022 and bottomed at 0.02 in Q2 2025.
  • The 5-year median for Asset Utilization Ratio is 0.06 (2023), against an average of 0.26.
  • The largest annual shift saw Asset Utilization Ratio skyrocketed 1916.73% in 2022 before it crashed 94.04% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.69 in 2021, then fell by 10.83% to 0.62 in 2022, then tumbled by 92.96% to 0.04 in 2023, then increased by 10.39% to 0.05 in 2024, then skyrocketed by 41.26% to 0.07 in 2025.
  • Per Business Quant, the three most recent readings for VIR's Asset Utilization Ratio are 0.07 (Q4 2025), 0.02 (Q3 2025), and 0.02 (Q2 2025).